Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)

Bibliographic Details
Main Authors:	Powles, Thomas, Nickles, Dorothee, Van Allen, Eliezer, Chappey, Colombe, Zou, Wei, Kowanetz, Marcin, Kadel, Edward, Denker, Mitchell, Boyd, Zachary, Vogelzang, Nicholas, Kim, Joseph, Bellmunt, Joaquim, Loriot, Yohann, Drake, Charles G, O'Hear, Carol, Fasso, Marcella, Hegde, Priti, Mariathasan, Sanjeev
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645499/

Similar Items

Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer
by: Xiao, Yuanyuan, et al.
Published: (2014)

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
by: Kowanetz, M, et al.
Published: (2014)

Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
by: Kowanetz, Marcin, et al.
Published: (2014)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
by: Kohrt, Holbrook, et al.
Published: (2013)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
by: Cha, E
Published: (2014)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
by: Carbognin, Luisa, et al.
Published: (2015)

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
by: Wallin, Jeffrey J., et al.
Published: (2016)

Modeling UBC intrinsic excitability
by: Subramaniyam, Sathyaa, et al.
Published: (2011)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
by: Facchinetti F, et al.
Published: (2018-09-01)

Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma
by: Phatcharawat Chirasuthat, et al.
Published: (2018-08-01)

Ubc9 expression predicts chemoresistance in breast cancer
by: Chen, Shi-Feng, et al.
Published: (2011)

Is Transthyretin a Regulator of Ubc9 SUMOylation?
by: Wieczorek, Elżbieta, et al.
Published: (2016)

Observation of an E2 (Ubc9)-homodimer by crystallography
by: Alontaga, Aileen Y., et al.
Published: (2016)

UBC develops North America’s greenest building
Published: (2010)

A BAC library of the SP80-3280 sugarcane variety (saccharum sp.) and its inferred microsynteny with the sorghum genome
by: Figueira, Thais Rezende e Silva, et al.
Published: (2012)

Complex Structure of OspI and Ubc13: The Molecular Basis of Ubc13 Deamidation and Convergence of Bacterial and Host E2 Recognition
by: Fu, Panhan, et al.
Published: (2013)

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors
by: Mizugaki, Hidenori, et al.
Published: (2016)

UBC Urus Projek Perundingan RM15 Juta Tahun 2007
by: Universiti Putra Malaysia, Bahagian Komunikasi Korporat
Published: (2008)

Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation
by: Jakobs, Astrid, et al.
Published: (2007)

Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity
by: Su, Yee-Fun, et al.
Published: (2012)

Feasibility Study of Mass-Timber Cores for the UBC Tall Wood Building
by: Thomas Connolly, et al.
Published: (2018-08-01)

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections
by: Mattoscio, Domenico, et al.
Published: (2015)

microRNA-214-mediated UBC9 expression in glioma
by: Zhao, Zhiqiang, et al.
Published: (2012)

Largest retrofit in Canada's history saves UBC $2.6 million annually
Published: (2006)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
by: Wang, Na-Na, et al.
Published: (2015)

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
by: Fizazi, Karim, et al.
Published: (2015)

Characterization of expression patterns of RPL27, UBC9, and SYNJ2 genes in normal and tumour human cell lines
by: Shanmugapriya,
Published: (2014)

GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance
by: Kampmann, Ulla, et al.
Published: (2011)

Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families
by: Vuorela, Mikko, et al.
Published: (2011)

Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A
by: Andersen, Parker L., et al.
Published: (2005)

Perturbation of the Hematopoietic System during Embryonic Liver Development Due to Disruption of Polyubiquitin Gene Ubc in Mice
by: Ryu, Kwon-Yul, et al.
Published: (2012)

Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells
by: Chang, Jae-Hoon, et al.
Published: (2012)

Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome
by: Kfoury, Youmna, et al.
Published: (2011)

Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage
by: Lee, Yang-ja, et al.
Published: (2011)

Proteasome Inhibition Promotes Parkin-Ubc13 Interaction and Lysine 63-Linked Ubiquitination
by: Lim, Grace G. Y., et al.
Published: (2013)

UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids
by: Wenzel, Dawn M., et al.
Published: (2011)

Polymorphism of UBC9 Gene Encoding the SUMO-E2-Conjugating Enzyme and Breast Cancer Risk
by: Wozniak, Katarzyna, et al.
Published: (2013)

Draft Genome Sequence of a Rare Smut Relative, Tilletiaria anomala UBC 951
by: Toome, Merje, et al.
Published: (2014)

Development of design response spectra for Northern Peninsular Malaysia based on UBC 97 code
by: Husna Zayadi
Published: (2008)

Social media for health care managers: creating a workshop in collaboration with the UBC Centre for Health Care Management
by: Kevin Read, et al.
Published: (2011-12-01)